Poston, Kathleen L.

AAV2-GAD gene therapy for advanced Parkinson’s disease: a double-blind, sham-surgery controlled, randomised trial

LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology

Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments

Cited by 681

Multimodal deep learning for Alzheimer's disease dementia assessment

Qiu, S., Miller, M. I., Joshi, P. S., Lee, J. C., Xue, C., Ni, Y., Wang, Y., De Anda-Duran, I., Hwang, P. H., Cramer, J. A., et al. (2022) · Nature Communications

Dementia and Cognitive Impairment ResearchArtificial Intelligence in Healthcare

Cited by 420

AI-based differential diagnosis of dementia etiologies on multimodal data

Xue, C., Kowshik, S. S., Lteif, D., Puducheri, S., Jasodanand, V. H., Zhou, O. T., Walia, A. S., Guney, O. B., Zhang, J. D., Poésy, S., et al. (2024) · Nature Medicine

Dementia and Cognitive Impairment ResearchArtificial Intelligence in Healthcare

Cited by 182

Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson’s disease

Sundaram, S., Hughes, R. L., Peterson, E., Müller-Oehring, E. M., Brontë-Stewart, H. M., Poston, K. L., Faerman, A., Bhowmick, C., & Schulte, T. (2019) · Neuroscience & Biobehavioral Reviews

Cerebrospinal fluid and hydrocephalusParkinson's Disease Mechanisms and Treatments

Cited by 152

Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease

Niethammer, M., Tang, C. C., LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Sarkar, A., et al. (2017) · JCI Insight

Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments

Cited by 124

APOE effects on regional tau in preclinical Alzheimer’s disease

Young, C. B., Johns, E., Kennedy, G., Belloy, M. E., Insel, P. S., Greicius, M. D., Sperling, R. A., Johnson, K. A., Poston, K. L., Mormino, E. C., et al. (2023) · Molecular Neurodegeneration

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 80

Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease

Young, C. B., Winer, J. R., Younes, K., Cody, K. A., Betthauser, T. J., Johnson, S. C., Schultz, A., Sperling, R. A., Greicius, M. D., Cobos, I., et al. (2022) · JAMA Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 79

Parkinson’s progression markers initiative: a milestone-based strategy to monitor Parkinson’s disease progression

Brumm, M. C., Siderowf, A., Simuni, T., Burghardt, E., Choi, S. H., Caspell-Garcia, C., Chahine, L. M., Mollenhauer, B., Foroud, T., Galasko, D., et al. (2023) · Journal of Parkinson’s Disease

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 70

Impaired 24-h activity patterns are associated with an increased risk of Alzheimer's disease, Parkinson's disease, and cognitive decline

Winer, J. R., Lok, R., Weed, L., He, Z., Poston, K. L., Mormino, E. C., & Zeitzer, J. M. (2024) · Alzheimer's Research & Therapy

Dementia and Cognitive Impairment ResearchCircadian rhythm and melatonin

Cited by 44

Speech patterns during memory recall relates to early tau burden across adulthood

Young, C. B., Smith, V., Karjadi, C., Grogan, S., Ang, T. F. A., Insel, P. S., Henderson, V. W., Sumner, M., Poston, K. L., Au, R., et al. (2024) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 27